Evidence map›Paper›PMID 31347718›Full record

ArticleJournal of cellular biochemistry2019

New strategy of bone marrow mesenchymal stem cells against oxidative stress injury via Nrf2 pathway: oxidative stress preconditioning.

Fei Zhang, Wuxun Peng, Jian Zhang, Wentao Dong, Dajiang Yuan, Yinggang Zheng, Zhenwen Wang

Open access · hybridAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Conditioned Medium from HAntioxidants (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fei ZhangDepartment of Trauma orthopedics, The Affliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Wuxun PengDepartment of Trauma orthopedics, The Affliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.ORCID 0000-0001-9468-2580
Jian ZhangDepartment of Trauma orthopedics, The Affliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Wentao DongDepartment of Trauma orthopedics, The Affliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Dajiang YuanTrauma Teaching and Research Department, Guizhou Medical University, Guiyang, Guizhou, China.
Yinggang ZhengTrauma Teaching and Research Department, Guizhou Medical University, Guiyang, Guizhou, China.
Zhenwen WangTrauma Teaching and Research Department, Guizhou Medical University, Guiyang, Guizhou, China.
Guiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinically, bone marrow mesenchymal stem cells (BMSCs) have been used in treatment of many diseases, but the local oxidative stress (OS) of lesion severely limits the survival of BMSCs, which reduces the efficacy of BMSCs transplantation. Therefore, enhancing the anti-OS stress ability of BMSCs is a key breakthrough point. Preconditioning is a common protective mechanism for cells or body. Here, the aim of this study was to investigate the effects of OS preconditioning on the anti-OS ability of BMSCs and its mechanism. Fortunately, OS preconditioning can increase the expression of superoxide dismutase, catalase, NQO1, and heme oxygenase 1 through the nuclear factor erythroid 2-related factor 2 pathway, thereby decreased the intracellular reactive oxygen species (ROS) levels, relieved the damage of ROS to mitochondria, DNA and cell membrane, enhanced the anti-OS ability of BMSCs, and promoted the survival of BMSCs under OS.

Indexed as

AnimalsApoptosisBone Marrow CellsCatalaseCells, CulturedDNA DamageDose-Response Relationship, DrugHydrogen PeroxideMaleMalondialdehydeMembrane Potential, MitochondrialMesenchymal Stem CellsNF-E2-Related Factor 2Oxidative StressRabbitsReactive Oxygen SpeciesCatalaseHydrogen PeroxideMalondialdehydeNF-E2-Related Factor 2Reactive Oxygen SpeciesSuperoxide Dismutasebone marrow mesenchymal stem cellsoxidative stresspreconditioningreactive oxygen species

Identifiers

PMID31347718
PMCPMC6852471
OpenAlexW2964626344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.